Abstract
Pediatric pharmacokinetic studies require sampling of biofluids from neonates and children. Limitations on sampling frequency and sample volume complicate the design of these studies. In addition, strict guidelines, designed to guarantee patient safety, are in place. This chapter describes the practical implications of sample collection and their storage, with special focus on the selection of the appropriate type of biofluid and withdrawal technique. In addition, we describe appropriate measures for storage of these specimens, for example, in the context of biobanking, and the requirements on drug assay methods that they pose. Pharmacokinetic studies in children are possible, but they require careful selection of an appropriate sampling method, specimen volume, and assay method. The checklist provided could help prospective researchers with the design of an appropriate study protocol and infrastructure.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aburuz S, Millership J, McElnay J (2006) Dried blood spot liquid chromatography assay for therapeutic drug monitoring of metformin. J Chromatogr B Analyt Technol Biomed Life Sci 832:202–207
Ahsman MJ, Wildschut ED, Tibboel D, Mathot RA (2009) Microanalysis of beta-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates. Antimicrob Agents Chemother 53:75–80
Ahsman MJ, Van der Nagel BC, Mathot RA (2010) Quantification of midazolam, morphine and metabolites in plasma using 96-well solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 24(9):969–976
Allegaert K, Rayyan M, de Hoon J, Tibboel D, Verbesselt R, Naulaers G, Van den Anker JN, Devlieger H (2006) Contribution of glucuronidation to tramadol disposition in early neonatal life. Basic Clin Pharmacol Toxicol 98:110–112
Anonymous (2000) E11: Guidance for industry – clinical investigation of medicinal products in the pediatric population. US Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD
Anonymous (2001a) Clinical investigation of medicinal products in the paediatric population, vol E11. European Medicines Agency, London
Anonymous (2001b) Guidance for industry – bioanalytical method validation. Biopharmaceutics Coordinating Committee, Center for Drug Evaluation and Research, US Food and Drug Administration, Rockville, MD
Anonymous (2004) The Hospital for Sick Children (SickKids) Research Ethics Board Blood Sampling Guidelines. Toronto
Anonymous (2008) E11: Ethical considerations for clinical trials on medicinal products with the paediatric population. Guidelines for Directive 2001/20/EC. European Commission, Brussels
Anonymous (2009) Good Clinical Laboratory Practice (GCLP). World Health Organization Special Programme for Research and Training in Tropical Disease. WHO, Geneva
Burke N (1995) Alternative methods for newborn urine sample collection. Pediatr Nurs 21:546–549
Careri M, Mangia A (2006) Validation and qualification: the fitness for purpose of mass spectrometry-based analytical methods and analytical systems. Anal Bioanal Chem 386:38–45
Chen SH, Chen YH (1999) Pharmacokinetic applications of capillary electrophoresis. Electrophoresis 20:3259–3268
de Paula M, Saiz LC, Gonzalez-Revalderia J, Pascual T, Alberola C, Miravalles E (1998) Rifampicin causes false-positive immunoassay results for urine opiates. Clin Chem Lab Med 36:241–243
de Velde F, Alffenaar JW, Wessels AM, Greijdanus B, Uges DR (2009) Simultaneous determination of clarithromycin, rifampicin and their main metabolites in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 877:1771–1777
de Wildt SN, Knibbe CA (2009) Knowledge of developmental pharmacology and modeling approaches should be used to avoid useless trials in children. Eur J Clin Pharmacol 65:849–850, author reply 851–842
de Wildt SN, Kerkvliet KT, Wezenberg MG, Ottink S, Hop WC, Vulto AG, van Den Anker JN (2001) Use of saliva in therapeutic drug monitoring of caffeine in preterm infants. Ther Drug Monit 23:250–254
de Wildt SN, Berns MJ, van den Anker JN (2007) 13C-erythromycin breath test as a noninvasive measure of CYP3A activity in newborn infants: a pilot study. Ther Drug Monit 29:225–230
Drummer OH (2006) Drug testing in oral fluid. Clin Biochem Rev 27:147–159
Edelbroek PM, van der Heijden J, Stolk LM (2009) Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. Ther Drug Monit 31:327–336
Elliott P, Peakman TC (2008) The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol 37:234–244
Ezzelle J, Rodriguez-Chavez IR, Darden JM, Stirewalt M, Kunwar N, Hitchcock R, Walter T, D’Souza MP (2008) Guidelines on good clinical laboratory practice: bridging operations between research and clinical research laboratories. J Pharm Biomed Anal 46:18–29
Farin D, Kitzes-Cohen R, Piva G, Gozlan I (1999) High performance liquid chromatography method for the determination of meropenem in human plasma. Chromatographia 49:253–255
Fell JM, Thakkar H, Newman DJ, Price CP (1997) Measurement of albumin and low molecular weight proteins in the urine of newborn infants using a cotton wool ball collection method. Acta Paediatr 86:518–522
Frison G, Favretto D, Vogliardi S, Terranova C, Ferrara SD (2008) Quantification of citalopram or escitalopram and their demethylated metabolites in neonatal hair samples by liquid chromatography-tandem mass spectrometry. Ther Drug Monit 30:467–473
Gallardo E, Queiroz JA (2008) The role of alternative specimens in toxicological analysis. Biomed Chromatogr 22:795–821
Gomes NA, Vaidya VV, Pudage A, Joshi SS, Parekh SA (2008) Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for simultaneous determination of tenofovir and emtricitabine in human plasma and its application to a bioequivalence study. J Pharm Biomed Anal 48:918–926
Gray TR, Shakleya DM, Huestis MA (2009) A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium. Anal Bioanal Chem 393:1977–1990
Hawcutt DB, Rose AC, Nunn T, Turner MA (2008) NIHR Medicines for Children Research Network (MCRN): points to consider when planning the collection of blood samples in clinical trials of investigational medicinal products. MCRN Guide. NIHR, London
Helgesson G, Dillner J, Carlson J, Bartram CR, Hansson MG (2007) Ethical framework for previously collected biobank samples. Nat Biotechnol 25:973–976
Hernandez-Borges J, Borges-Miquel TM, Rodriguez-Delgado MA, Cifuentes A (2007) Sample treatments prior to capillary electrophoresis-mass spectrometry. J Chromatogr A 1153:214–226
Hoeyer K, Olofsson BO, Mjorndal T, Lynoe N (2005) The ethics of research using biobanks: reason to question the importance attributed to informed consent. Arch Intern Med 165:97–100
Hoogtanders K, van der Heijden J, Christiaans M, Edelbroek P, van Hooff JP, Stolk LM (2007) Therapeutic drug monitoring of tacrolimus with the dried blood spot method. J Pharm Biomed Anal 44:658–664
Hyotylainen T (2009) Critical evaluation of sample pretreatment techniques. Anal Bioanal Chem 394:743–758
Ince I, de Wildt SN, Tibboel D, Danhof M, Knibbe CA (2009) Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling. Drug Discov Today 14:316–320
Kacinko SL, Shakleya DM, Huestis MA (2008) Validation and application of a method for the determination of buprenorphine, norbuprenorphine, and their glucuronide conjugates in human meconium. Anal Chem 80:246–252
Koal T, Burhenne H, Romling R, Svoboda M, Resch K, Kaever V (2005) Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 19:2995–3001
la Marca G, Malvagia S, Filippi L, Fiorini P, Innocenti M, Luceri F, Pieraccini G, Moneti G, Francese S, Dani FR, Guerrini R (2008) Rapid assay of topiramate in dried blood spots by a new liquid chromatography-tandem mass spectrometric method. J Pharm Biomed Anal 48:1392–1396
Liang X, Li Y, Barfield M, Ji QC (2009) Study of dried blood spots technique for the determination of dextromethorphan and its metabolite dextrorphan in human whole blood by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 877:799–806
Marzo A, Bo LD (2007) Tandem mass spectrometry (LC-MS-MS): a predominant role in bioassays for pharmacokinetic studies. Arzneimittelforschung 57:122–128
Matuszewski BK (2006) Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis. J Chromatogr B Analyt Technol Biomed Life Sci 830:293–300
Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 75:3019–3030
Mehta AC (1989) Preanalytical considerations in drug assays in clinical pharmacokinetic studies. J Clin Pharm Ther 14:285–295
Moyer TP, Johnson P, Faynor SM, Sterioff S (1986) Cyclosporine: a review of drug monitoring problems and presentation of a simple, accurate liquid chromatographic procedure that solves these problems. Clin Biochem 19:83–89
Paine MF, Wagner DA, Hoffmaster KA, Watkins PB (2002) Cytochrome P450 3A4 and P-glycoprotein mediate the interaction between an oral erythromycin breath test and rifampin. Clin Pharmacol Ther 72:524–535
Patel BN, Sharma N, Sanyal M, Shrivastav PS (2009) An accurate, rapid and sensitive determination of tramadol and its active metabolite O-desmethyltramadol in human plasma by LC-MS/MS. J Pharm Biomed Anal 49:354–366
Peakman TC, Elliott P (2008) The UK Biobank sample handling and storage validation studies. Int J Epidemiol 37(Suppl 1):i2–i6
Pons G, Blais JC, Rey E, Plissonnier M, Richard MO, Carrier O, d’Athis P, Moran C, Badoual J, Olive G (1988) Maturation of caffeine N-demethylation in infancy: a study using the 13CO2 breath test. Pediatr Res 23:632–636
Premaud A, Rousseau A, Picard N, Marquet P (2006) Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry. Ther Drug Monit 28:274–277
Rigourd V, Amirouche A, Tasseau A, Kintz P, Serreau R (2008) Retrospective diagnosis of an adverse drug reaction in a breastfed neonate: liquid chromatography-tandem mass spectrometry quantification of dextropropoxyphene and norpropoxyphene in newborn and maternal hair. J Anal Toxicol 39:787–789
Saito Y, Jinno K (2003) Miniaturized sample preparation combined with liquid phase separations. J Chromatogr A 1000:53–67
Shen JX, Tama CI, Hayes RN (2006) Evaluation of automated micro solid phase extraction tips (micro-SPE) for the validation of a LC-MS/MS bioanalytical method. J Chromatogr B Analyt Technol Biomed Life Sci 843:275–282
Spooner N, Lad R, Barfield M (2009) Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. Anal Chem 81:1557–1563
Strazdins L, Meyerkort S, Brent V, D’Souza RM, Broom DH, Kyd JM (2005) Impact of saliva collection methods on sIgA and cortisol assays and acceptability to participants. J Immunol Methods 307:167–171
Streetman DS, Kashuba AD, Bertino JS Jr, Kulawy R, Rocci ML Jr, Nafziger AN (2001) Use of midazolam urinary metabolic ratios for cytochrome P450 3A (CYP3A) phenotyping. Pharmacogenetics 11:349–355
Sung WC, Chen SH (2006) Pharmacokinetic applications of capillary electrophoresis: a review on recent progress. Electrophoresis 27:257–265
Tate J, Ward G (2004) Interferences in immunoassay. Clin Biochem Rev 25:105–120
Taylor PJ (2005) Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem 38:328–334
Tribut O, Gaulier JM, Allain H, Bentue-Ferrer D (2005) Major discrepancy between digoxin immunoassay results in a context of acute overdose: a case report. Clin Chim Acta 354:201–203
Tucker GT, Rostami-Hodjegan A, Jackson PR (1998) Determination of drug-metabolizing enzyme activity in vivo: pharmacokinetic and statistical issues. Xenobiotica 28:1255–1273
van der Heijden J, de Beer Y, Hoogtanders K, Christiaans M, de Jong GJ, Neef C, Stolk L (2008) Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry. J Pharm Biomed Anal 50(4):664–670
van der Schoor SR, de Koning BA, Wattimena DL, Tibboel D, van Goudoever JB (2004) Validation of the direct nasopharyngeal sampling method for collection of expired air in preterm neonates. Pediatr Res 55:50–54
Vaught JB (2006) Blood collection, shipment, processing, and storage. Cancer Epidemiol Biomark Prev 15:1582–1584
Vogeser M (2003) Liquid chromatography-tandem mass spectrometry – application in the clinical laboratory. Clin Chem Lab Med 41:117–126
Witjes BC, Ahsman MJ, van der Nagel BC, Tibboel D, Mathot RA (2009) Simultaneous assay of sildenafil and desmethylsildenafil in neonatal plasma by ultra-performance liquid chromatography-tandem mass spectrometry. Biomed Chromatogr 24(2):180–185
Yeh RF, Rezk NL, Kashuba AD, Dumond JB, Tappouni HL, Tien HC, Chen YC, Vourvahis M, Horton AL, Fiscus SA, Patterson KB (2009) Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women. Antimicrob Agents Chemother 53:2367–2374
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ahsman, M.J., Tibboel, D., Mathot, R.A.A., de Wildt, S.N. (2011). Sample Collection, Biobanking, and Analysis. In: Seyberth, H., Rane, A., Schwab, M. (eds) Pediatric Clinical Pharmacology. Handbook of Experimental Pharmacology, vol 205. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20195-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-20195-0_10
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-20194-3
Online ISBN: 978-3-642-20195-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)